vs
メドトロニック（MDT）とPNC Financial Services（PNC）の財務データ比較。上の社名をクリックして会社を切り替えられます
メドトロニックの直近四半期売上が大きい（$9.0B vs $6.1B、PNC Financial Servicesの約1.5倍）。PNC Financial Servicesの純利益率が高く（33.5% vs 15.3%、差は18.2%）。PNC Financial Servicesの前年同期比売上増加率が高い（9.1% vs 6.6%）。過去8四半期でPNC Financial Servicesの売上複合成長率が高い（8.6% vs 5.3%）
メドトロニックはアイルランドに籍を置く医療機器企業です。法務・経営本部はアイルランドに、業務執行本部は米国ミネソタ州ミネアポリスに所在し、2015年にアイルランドのコヴィディエン買収を機にアイルランドに本拠を移転しました。現在150カ国以上で事業を展開し、従業員数は9万人を超え、医療技術や治療法の開発・製造を行っています。
PNCフィナンシャル・サービシズ・グループは米国ペンシルベニア州ピッツバーグに本社を置く銀行持株会社兼金融サービス企業です。子会社のPNC銀行は米国27州とコロンビア特別区で事業を展開し、2629店舗と9523台のATMを運営しており、米国最大級の銀行の1つです。
MDT vs PNC — 直接比較
売上が大きい
MDT
1.5倍大きい
$6.1B
売上成長率が高い
PNC
+2.4%の差
6.6%
純利益率が高い
PNC
純利益率が18.2%高い
15.3%
2年売上CAGRが高い
PNC
2年複合成長率
5.3%
損益計算書 — Q2 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $9.0B | $6.1B |
| 純利益 | $1.4B | $2.0B |
| 粗利率 | 65.8% | — |
| 営業利益率 | 18.8% | 38.4% |
| 純利益率 | 15.3% | 33.5% |
| 売上前年比 | 6.6% | 9.1% |
| 純利益前年比 | 8.2% | 25.0% |
| EPS（希薄化後） | $1.07 | $4.88 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上MDTPNC
| Q4 25 | $9.0B | $6.1B | ||
| Q3 25 | $8.6B | $5.9B | ||
| Q2 25 | $8.9B | $5.7B | ||
| Q1 25 | $8.3B | $5.5B | ||
| Q4 24 | $8.4B | $5.6B | ||
| Q3 24 | $7.9B | $5.4B | ||
| Q2 24 | $8.6B | $5.4B | ||
| Q1 24 | $8.1B | $5.1B |
純利益MDTPNC
| Q4 25 | $1.4B | $2.0B | ||
| Q3 25 | $1.0B | $1.8B | ||
| Q2 25 | $1.1B | $1.6B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | $1.3B | $1.6B | ||
| Q3 24 | $1.0B | $1.5B | ||
| Q2 24 | $654.0M | $1.5B | ||
| Q1 24 | $1.3B | $1.3B |
粗利率MDTPNC
| Q4 25 | 65.8% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 64.8% | — | ||
| Q1 25 | 66.5% | — | ||
| Q4 24 | 64.9% | — | ||
| Q3 24 | 65.1% | — | ||
| Q2 24 | 64.5% | — | ||
| Q1 24 | 65.6% | — |
営業利益率MDTPNC
| Q4 25 | 18.8% | 38.4% | ||
| Q3 25 | 16.8% | 38.7% | ||
| Q2 25 | 16.1% | 35.8% | ||
| Q1 25 | 19.9% | 33.9% | ||
| Q4 24 | 19.0% | 34.2% | ||
| Q3 24 | 16.1% | 34.3% | ||
| Q2 24 | 12.3% | 33.6% | ||
| Q1 24 | 18.3% | 32.2% |
純利益率MDTPNC
| Q4 25 | 15.3% | 33.5% | ||
| Q3 25 | 12.1% | 30.8% | ||
| Q2 25 | 11.8% | 29.0% | ||
| Q1 25 | 15.6% | 27.5% | ||
| Q4 24 | 15.1% | 29.2% | ||
| Q3 24 | 13.2% | 27.7% | ||
| Q2 24 | 7.6% | 27.3% | ||
| Q1 24 | 16.3% | 26.1% |
EPS（希薄化後）MDTPNC
| Q4 25 | $1.07 | $4.88 | ||
| Q3 25 | $0.81 | $4.35 | ||
| Q2 25 | $0.81 | $3.85 | ||
| Q1 25 | $1.01 | $3.51 | ||
| Q4 24 | $0.99 | $3.76 | ||
| Q3 24 | $0.80 | $3.49 | ||
| Q2 24 | $0.50 | $3.39 | ||
| Q1 24 | $0.99 | $3.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $8.3B | — |
| 総負債低いほど良い | $27.7B | $57.1B |
| 株主資本純資産 | $48.7B | $60.6B |
| 総資産 | $91.3B | $573.6B |
| 負債/資本比率低いほどレバレッジが低い | 0.57× | 0.94× |
8四半期トレンド — 暦四半期で整列
現金・短期投資MDTPNC
| Q4 25 | $8.3B | — | ||
| Q3 25 | $8.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $7.9B | — | ||
| Q4 24 | $8.0B | — | ||
| Q3 24 | $7.8B | — | ||
| Q2 24 | $8.0B | — | ||
| Q1 24 | $8.3B | — |
総負債MDTPNC
| Q4 25 | $27.7B | $57.1B | ||
| Q3 25 | $26.2B | $62.3B | ||
| Q2 25 | $25.6B | $60.4B | ||
| Q1 25 | $24.0B | $60.7B | ||
| Q4 24 | $24.6B | $61.7B | ||
| Q3 24 | $26.3B | $68.1B | ||
| Q2 24 | $23.9B | $71.4B | ||
| Q1 24 | $24.2B | $72.7B |
株主資本MDTPNC
| Q4 25 | $48.7B | $60.6B | ||
| Q3 25 | $47.9B | $59.0B | ||
| Q2 25 | $48.0B | $57.6B | ||
| Q1 25 | $49.4B | $56.4B | ||
| Q4 24 | $48.5B | $54.4B | ||
| Q3 24 | $47.9B | $55.7B | ||
| Q2 24 | $50.2B | $52.6B | ||
| Q1 24 | $51.8B | $51.3B |
総資産MDTPNC
| Q4 25 | $91.3B | $573.6B | ||
| Q3 25 | $91.0B | $568.8B | ||
| Q2 25 | $91.7B | $559.1B | ||
| Q1 25 | $90.0B | $554.7B | ||
| Q4 24 | $90.0B | $560.0B | ||
| Q3 24 | $89.7B | $564.9B | ||
| Q2 24 | $90.0B | $556.5B | ||
| Q1 24 | $90.8B | $566.2B |
負債/資本比率MDTPNC
| Q4 25 | 0.57× | 0.94× | ||
| Q3 25 | 0.55× | 1.06× | ||
| Q2 25 | 0.53× | 1.05× | ||
| Q1 25 | 0.49× | 1.08× | ||
| Q4 24 | 0.51× | 1.13× | ||
| Q3 24 | 0.55× | 1.22× | ||
| Q2 24 | 0.48× | 1.36× | ||
| Q1 24 | 0.47× | 1.42× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $925.0M | $757.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $457.0M | — |
| FCFマージンFCF / 売上 | 5.1% | — |
| 設備投資強度設備投資 / 売上 | 5.2% | — |
| キャッシュ転換率営業CF / 純利益 | 0.67× | 0.37× |
| 直近12ヶ月FCF直近4四半期 | $5.2B | — |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローMDTPNC
| Q4 25 | $925.0M | $757.0M | ||
| Q3 25 | $1.1B | $2.7B | ||
| Q2 25 | $2.5B | $1.5B | ||
| Q1 25 | $2.6B | $-509.0M | ||
| Q4 24 | $958.0M | $1.8B | ||
| Q3 24 | $986.0M | $3.3B | ||
| Q2 24 | $2.8B | $1.0B | ||
| Q1 24 | $2.5B | $1.8B |
フリーキャッシュフローMDTPNC
| Q4 25 | $457.0M | — | ||
| Q3 25 | $584.0M | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $554.0M | — | ||
| Q3 24 | $466.0M | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.1B | — |
FCFマージンMDTPNC
| Q4 25 | 5.1% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 23.2% | — | ||
| Q1 25 | 25.3% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 27.4% | — | ||
| Q1 24 | 26.3% | — |
設備投資強度MDTPNC
| Q4 25 | 5.2% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 5.0% | — | ||
| Q1 24 | 4.3% | — |
キャッシュ転換率MDTPNC
| Q4 25 | 0.67× | 0.37× | ||
| Q3 25 | 1.05× | 1.46× | ||
| Q2 25 | 2.39× | 0.90× | ||
| Q1 25 | 1.99× | -0.34× | ||
| Q4 24 | 0.75× | 1.11× | ||
| Q3 24 | 0.95× | 2.18× | ||
| Q2 24 | 4.25× | 0.70× | ||
| Q1 24 | 1.87× | 1.31× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MDT
| Cardiac Rhythm And Heart Failure Division | $1.8B | 20% |
| Surgical Endoscopy | $1.7B | 19% |
| Other | $1.3B | 14% |
| Structural Heart And Aortic Division | $956.0M | 11% |
| Diabetes Group | $757.0M | 8% |
| Specialty Therapies Division | $744.0M | 8% |
| Coronary And Peripheral Vascular Division | $655.0M | 7% |
| Neuromodulation Division | $520.0M | 6% |
| Acute Care Monitoring | $493.0M | 6% |
| IE | $35.0M | 0% |
PNC
| Corporate Institutional Banking Segment | $3.0B | 50% |
| Other | $2.5B | 42% |
| Interchange Fees | $181.0M | 3% |
| Asset Management Fees And Brokerage Fees | $155.0M | 3% |
| Net Credit Card Fees | $59.0M | 1% |
| Merchant Fees | $32.0M | 1% |
| Commercial And Residential Mortgage Banking Fees | $25.0M | 0% |
| Cash And Cash Management Fees Other | $20.0M | 0% |
| Lending And Deposit Services Other | $18.0M | 0% |
| Treasury Management Fees | $10.0M | 0% |
